BridgeBio Pharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $595.7M | $703.6M | $356.1M |
| FY2021 | $1.88B | $1.01B | $393.8M |
| FY2022 | $1.87B | $623.0M | $376.7M |
| FY2023 | $1.89B | $546.4M | $375.9M |
| FY2024 | $2.38B | $919.3M | $681.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $595.7M | $703.6M | $356.1M |
| FY2021 | $1.88B | $1.01B | $393.8M |
| FY2022 | $1.87B | $623.0M | $376.7M |
| FY2023 | $1.89B | $546.4M | $375.9M |
| FY2024 | $2.38B | $919.3M | $681.1M |